MEDIATORS OF RESTENOSIS
Authors:
- 1 June 1998
- journal article
- review article
- Published by Elsevier in Surgical Clinics of North America
- Vol. 78 (3) , 481-500
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Thrombin-Mediated Increase in Vascular Endothelial PermeabilitySeminars in Thrombosis and Hemostasis, 1992
- Ultrastructure appearance of atherosclerosis in human and experimentally-induced animal modelsElectron Microscopy Reviews, 1992
- DEFINITION OF TYPE I and TYPE II PHOTOSENSITIZED OXIDATIONPhotochemistry and Photobiology, 1991
- The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1990
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplastyAmerican Heart Journal, 1989
- Alpha-thrombin induces release of platelet-derived growth factor-like molecule(s) by cultured human endothelial cells.Journal of Cell Biology, 1986
- Antiplatelet Drugs in the Management of Patients with Thrombotic DisordersSeminars in Thrombosis and Hemostasis, 1986